Literature DB >> 33557437

Osteoclasts Differentiation from Murine RAW 264.7 Cells Stimulated by RANKL: Timing and Behavior.

Nadia Lampiasi1, Roberta Russo1, Igor Kireev2, Olga Strelkova2, Oxana Zhironkina2, Francesca Zito1.   

Abstract

The development of multi-nucleated cells is critical for osteoclasts (OCs) maturation and function. Our objective was to extend knowledge on osteoclastogenesis, focusing on pre-OC fusion timing and behavior. RAW 264.7 cells, which is a murine monocyte-macrophage cell line, provide a valuable and widely used tool for in vitro studies on osteoclastogenesis mechanisms. Cells were treated with the receptor activator of nuclear factor κ-B ligand (RANKL) for 1-4 days and effects on cell morphology, cytoskeletal organization, protein distribution, and OC-specific gene expression examined by TEM, immunofluorescence, and qPCR. Multinucleated cells began to appear at two days of Receptor Activator of Nuclear factor κ-B Ligand (RANKL) stimulation, increasing in number and size in the following days, associated with morphological and cytoskeletal organization changes. Interesting cellular extensions were observed in three days within cells labeled with wheat germ agglutinin (WGA)-Fluorescein isothiocyanate (FITC). The membrane, cytoplasmic, or nuclear distribution of RANK, TRAF6, p-p38, pERK1/2, and NFATc1, respectively, was related to OCs maturation timing. The gene expression for transcription factors regulating osteoclastogenesis (NFATc1, c-fos, RelA, MITF), molecules involved in RANKL-signaling transduction (TRAF6), cytoskeleton regulation (RhoA), fusion (DC-STAMP), migration (MMP9), and OC-specific enzymes (TRAP, CtsK), showed different trends related to OC differentiation timing. Our findings provide an integrated view on the morphological and molecular changes occurring during RANKL stimulation of RAW 264.7 cells, which are important to better understand the OCs' maturation processes.

Entities:  

Keywords:  NFATc1; RANK localization; WGA-FITC labeling; migrasomes; multinucleated cell; nuclear co-localization; p-ERK; p-p38

Year:  2021        PMID: 33557437      PMCID: PMC7915339          DOI: 10.3390/biology10020117

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  33 in total

1.  The elementary fusion modalities of osteoclasts.

Authors:  Kent Søe; Anne-Sofie Hobolt-Pedersen; Jean-Marie Delaisse
Journal:  Bone       Date:  2014-12-16       Impact factor: 4.398

2.  Osteoclast fusion is initiated by a small subset of RANKL-stimulated monocyte progenitors, which can fuse to RANKL-unstimulated progenitors.

Authors:  Noam Levaot; Aner Ottolenghi; Mati Mann; Gali Guterman-Ram; Zvi Kam; Benjamin Geiger
Journal:  Bone       Date:  2015-05-22       Impact factor: 4.398

3.  Migrasome formation is mediated by assembly of micron-scale tetraspanin macrodomains.

Authors:  Yuwei Huang; Ben Zucker; Shaojin Zhang; Sharon Elias; Yun Zhu; Hui Chen; Tianlun Ding; Ying Li; Yujie Sun; Jizhong Lou; Michael M Kozlov; Li Yu
Journal:  Nat Cell Biol       Date:  2019-08-01       Impact factor: 28.824

4.  RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.

Authors:  Gerald J Atkins; Panagiota Kostakis; Cristina Vincent; Amanda N Farrugia; Jeffrey P Houchins; David M Findlay; Andreas Evdokiou; Andrew C W Zannettino
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

5.  Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).

Authors:  M Matsumoto; T Sudo; T Saito; H Osada; M Tsujimoto
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.

Authors:  Alexander David Barrow; Nicolas Raynal; Thomas Levin Andersen; David A Slatter; Dominique Bihan; Nicholas Pugh; Marina Cella; Taesoo Kim; Jaerang Rho; Takako Negishi-Koga; Jean-Marie Delaisse; Hiroshi Takayanagi; Joseph Lorenzo; Marco Colonna; Richard W Farndale; Yongwon Choi; John Trowsdale
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

7.  Regulation of Osteoclast Multinucleation by the Actin Cytoskeleton Signaling Network.

Authors:  Jiro Takito; Hirotada Otsuka; Nobuaki Yanagisawa; Hiroshi Arai; Masayasu Shiga; Mitsuko Inoue; Naoko Nonaka; Masanori Nakamura
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

8.  Gene Expression Profiling of NFATc1-Knockdown in RAW 264.7 Cells: An Alternative Pathway for Macrophage Differentiation.

Authors:  Roberta Russo; Selene Mallia; Francesca Zito; Nadia Lampiasi
Journal:  Cells       Date:  2019-02-07       Impact factor: 6.600

Review 9.  Regulation of NFATc1 in Osteoclast Differentiation.

Authors:  Jung Ha Kim; Nacksung Kim
Journal:  J Bone Metab       Date:  2014-11-30

10.  Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation.

Authors:  Kyunghee Lee; Yeoun Ho Chung; Heejin Ahn; Hyunsoo Kim; Jaerang Rho; Daewon Jeong
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

View more
  6 in total

1.  Nucleotides modulate synoviocyte proliferation and osteoclast differentiation in macrophages with potential implications for rheumatoid arthritis.

Authors:  Sai Krishna Srimadh Bhagavatham; Vishnu Kannan; V M Datta Darshan; Venketesh Sivaramakrishnan
Journal:  3 Biotech       Date:  2021-11-19       Impact factor: 2.406

Review 2.  Migrasomes: From Biogenesis, Release, Uptake, Rupture to Homeostasis and Diseases.

Authors:  Yaxing Zhang; Wenhai Guo; Mingmin Bi; Wei Liu; Lequan Zhou; Haimei Liu; Fuman Yan; Li Guan; Jiongshan Zhang; Jinwen Xu
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

3.  Effects of Artemisia annua L. Essential Oil on Osteoclast Differentiation and Function Induced by RANKL.

Authors:  Wen Sun; Guangyue Yang; Fang Zhang; Chenguo Feng; Mingjie Liang; Pengfei Jia; Zhongliang Zhao; Hailing Guo; Yongfang Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-07       Impact factor: 2.650

4.  Novel NFκB Inhibitor SC75741 Mitigates Chondrocyte Degradation and Prevents Activated Fibroblast Transformation by Modulating miR-21/GDF-5/SOX5 Signaling.

Authors:  Pei-Wei Weng; Vijesh Kumar Yadav; Narpati Wesa Pikatan; Iat-Hang Fong; I-Hsin Lin; Chi-Tai Yeh; Wei-Hwa Lee
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 6.208

5.  Engineering 3D Printed Scaffolds with Tunable Hydroxyapatite.

Authors:  Yoontae Kim; Eun-Jin Lee; Anthony P Kotula; Shozo Takagi; Laurence Chow; Stella Alimperti
Journal:  J Funct Biomater       Date:  2022-03-23

6.  Photothermal-Controlled Release of IL-4 in IL-4/PDA-Immobilized Black Titanium Dioxide (TiO2) Nanotubes Surface to Enhance Osseointegration: An In Vivo Study.

Authors:  Bo Chen; Yu Liang; Yunjia Song; Yunkai Liang; Jian Jiao; Hong Bai; Ying Li
Journal:  Materials (Basel)       Date:  2022-08-29       Impact factor: 3.748

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.